_id
69148525ccc777a4e85d9578
Ticker
NVNBW
Name
enVVeno Medical Corporation
Exchange
PINK
Address
70 Doppler, Irvine, CA, United States, 92618
Country
USA
Sector
Industry
Currency
USD
Website
https://www.envveno.com
Description
enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease. The company's lead product is the VenoValve, a replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
Last Close
0.007
Volume
-
Current Price
0.007
Change
0
Last Updated
2026-01-05T11:49:41.998Z
Image
-
Ipo Date
-
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
4883000
Operating Income
-4883000
Interest Expense
-
Pretax Income
-4539000
Net Income
-4539000
Eps
-0.2252046638551228
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-4433498
Operating Margin
-
Total Other Income Expense Net
344000
Cash
1544000
Short Term Investments
29408000
Receivables
-
Inventories
-
Total Current Assets
31499000
Property Plant Equipment
822000
Total Assets
32352000
Payables
626000
Short Term Debt
286000
Long Term Debt
-
Total Liabilities
2905000
Equity
29447000
Bs_currency_symbol
USD
Depreciation
105502
Change In Working Capital
-602747
Cash From Operations
-3045023
Capital Expenditures
126482
Cash From Investing
-1676482
Cash From Financing
241000
Net Change In Cash
-500000
Cf_currency_symbol
USD
PE
-
PB
0.004791150202057935
ROE
-15.414133867626584
ROA
-14.030044510385755
FCF
-3171505
Fcf Percent
-
Piotroski FScore
1
Health Score
42
Deep Value Investing Score
4.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
4883000
Quarters > 0 > income Statement > operating Income
-4883000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-4539000
Quarters > 0 > income Statement > net Income
-4539000
Quarters > 0 > income Statement > eps
-0.2252046638551228
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
20155000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-4433498
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
344000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
1544000
Quarters > 0 > balance Sheet > short Term Investments
29408000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
31499000
Quarters > 0 > balance Sheet > property Plant Equipment
822000
Quarters > 0 > balance Sheet > total Assets
32352000
Quarters > 0 > balance Sheet > payables
626000
Quarters > 0 > balance Sheet > short Term Debt
286000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2905000
Quarters > 0 > balance Sheet > equity
29447000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-2413895
Quarters > 0 > cash Flow > depreciation
105502
Quarters > 0 > cash Flow > change In Working Capital
-602747
Quarters > 0 > cash Flow > cash From Operations
-3045023
Quarters > 0 > cash Flow > capital Expenditures
126482
Quarters > 0 > cash Flow > cash From Investing
-1676482
Quarters > 0 > cash Flow > cash From Financing
241000
Quarters > 0 > cash Flow > net Change In Cash
-500000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.2252046638551228
Quarters > 0 > ratios > PB
0.004791150202057935
Quarters > 0 > ratios > ROE
-15.414133867626584
Quarters > 0 > ratios > ROA
-14.030044510385755
Quarters > 0 > ratios > FCF
-3171505
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
130000
Quarters > 1 > income Statement > gross Profit
-130000
Quarters > 1 > income Statement > operating Expenses
6919000
Quarters > 1 > income Statement > operating Income
-7049000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-6694000
Quarters > 1 > income Statement > net Income
-6694000
Quarters > 1 > income Statement > eps
-0.3289111635220126
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
20352000
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-6564000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
355000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
2044000
Quarters > 1 > balance Sheet > short Term Investments
33098000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
35604000
Quarters > 1 > balance Sheet > property Plant Equipment
942000
Quarters > 1 > balance Sheet > total Assets
36577000
Quarters > 1 > balance Sheet > payables
1073000
Quarters > 1 > balance Sheet > short Term Debt
377000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
3520000
Quarters > 1 > balance Sheet > equity
33057000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-8819105
Quarters > 1 > cash Flow > depreciation
144498
Quarters > 1 > cash Flow > change In Working Capital
1326000
Quarters > 1 > cash Flow > cash From Operations
-3715000
Quarters > 1 > cash Flow > capital Expenditures
121482
Quarters > 1 > cash Flow > cash From Investing
2822000
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-893000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.3289111635220126
Quarters > 1 > ratios > PB
0.004309646973409565
Quarters > 1 > ratios > ROE
-20.24987143418943
Quarters > 1 > ratios > ROA
-18.301118189025892
Quarters > 1 > ratios > FCF
-3836482
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
122000
Quarters > 2 > income Statement > gross Profit
-122000
Quarters > 2 > income Statement > operating Expenses
4832000
Quarters > 2 > income Statement > operating Income
-4954000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-4503000
Quarters > 2 > income Statement > net Income
-4503000
Quarters > 2 > income Statement > eps
-0.2212558962264151
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
20352000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-4381000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
451000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
2937000
Quarters > 2 > balance Sheet > short Term Investments
36004000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
39479000
Quarters > 2 > balance Sheet > property Plant Equipment
1067000
Quarters > 2 > balance Sheet > total Assets
40577000
Quarters > 2 > balance Sheet > payables
703000
Quarters > 2 > balance Sheet > short Term Debt
370000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2270000
Quarters > 2 > balance Sheet > equity
38307000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-4503000
Quarters > 2 > cash Flow > depreciation
122000
Quarters > 2 > cash Flow > change In Working Capital
-482000
Quarters > 2 > cash Flow > cash From Operations
-4018000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
5201000
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
1183000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.2212558962264151
Quarters > 2 > ratios > PB
0.003719006970005482
Quarters > 2 > ratios > ROE
-11.755031717440676
Quarters > 2 > ratios > ROA
-11.097419720531336
Quarters > 2 > ratios > FCF
-4018000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
812000
Quarters > 3 > income Statement > cost Of Revenue
406000
Quarters > 3 > income Statement > gross Profit
406000
Quarters > 3 > income Statement > operating Expenses
6976000
Quarters > 3 > income Statement > operating Income
-6699000
Quarters > 3 > income Statement > interest Expense
389000
Quarters > 3 > income Statement > pretax Income
-6229000
Quarters > 3 > income Statement > net Income
-6229000
Quarters > 3 > income Statement > eps
-0.36337650215844125
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
17142000
Quarters > 3 > income Statement > income Tax Expense
-97724
Quarters > 3 > income Statement > EBITDA
-6107000
Quarters > 3 > income Statement > operating Margin
-825
Quarters > 3 > income Statement > total Other Income Expense Net
470000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
1754000
Quarters > 3 > balance Sheet > short Term Investments
41399000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
43734000
Quarters > 3 > balance Sheet > property Plant Equipment
1189000
Quarters > 3 > balance Sheet > total Assets
44954000
Quarters > 3 > balance Sheet > payables
1006000
Quarters > 3 > balance Sheet > short Term Debt
364000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
2795000
Quarters > 3 > balance Sheet > equity
42159000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-6229000
Quarters > 3 > cash Flow > depreciation
122000
Quarters > 3 > cash Flow > change In Working Capital
-424000
Quarters > 3 > cash Flow > cash From Operations
-5105000
Quarters > 3 > cash Flow > capital Expenditures
4000
Quarters > 3 > cash Flow > cash From Investing
-11056000
Quarters > 3 > cash Flow > cash From Financing
38321776
Quarters > 3 > cash Flow > net Change In Cash
-16161000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.36337650215844125
Quarters > 3 > ratios > PB
0.0028462250053369388
Quarters > 3 > ratios > ROE
-14.775018382788966
Quarters > 3 > ratios > ROA
-13.856386528451306
Quarters > 3 > ratios > FCF
-5109000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-6.291871921182266
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
528000
Annuals > 0 > income Statement > gross Profit
-528000
Annuals > 0 > income Statement > operating Expenses
23298000
Annuals > 0 > income Statement > operating Income
-23826000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-21819000
Annuals > 0 > income Statement > net Income
-21819000
Annuals > 0 > income Statement > eps
-1.2728386419320965
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
17142000
Annuals > 0 > income Statement > income Tax Expense
-21819000
Annuals > 0 > income Statement > EBITDA
-21291000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
2007000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
1754000
Annuals > 0 > balance Sheet > short Term Investments
41399000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
43734000
Annuals > 0 > balance Sheet > property Plant Equipment
1189000
Annuals > 0 > balance Sheet > total Assets
44954000
Annuals > 0 > balance Sheet > payables
1006000
Annuals > 0 > balance Sheet > short Term Debt
364000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
2795000
Annuals > 0 > balance Sheet > equity
42159000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-21819000
Annuals > 0 > cash Flow > depreciation
528000
Annuals > 0 > cash Flow > change In Working Capital
290000
Annuals > 0 > cash Flow > cash From Operations
-16838000
Annuals > 0 > cash Flow > capital Expenditures
37000
Annuals > 0 > cash Flow > cash From Investing
1335000
Annuals > 0 > cash Flow > cash From Financing
13637000
Annuals > 0 > cash Flow > net Change In Cash
-1866000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-1.2728386419320965
Annuals > 0 > ratios > PB
0.0028462250053369388
Annuals > 0 > ratios > ROE
-51.75407386323205
Annuals > 0 > ratios > ROA
-48.53628153223295
Annuals > 0 > ratios > FCF
-16875000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
546000
Annuals > 1 > income Statement > gross Profit
-546000
Annuals > 1 > income Statement > operating Expenses
24692000
Annuals > 1 > income Statement > operating Income
-25238000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-23516000
Annuals > 1 > income Statement > net Income
-23516000
Annuals > 1 > income Statement > eps
-1.9117144947565239
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
12301000
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-22970000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
1722000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
3620000
Annuals > 1 > balance Sheet > short Term Investments
42792000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
46923000
Annuals > 1 > balance Sheet > property Plant Equipment
1681000
Annuals > 1 > balance Sheet > total Assets
48635000
Annuals > 1 > balance Sheet > payables
427000
Annuals > 1 > balance Sheet > short Term Debt
338000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
2435000
Annuals > 1 > balance Sheet > equity
46200000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-23516000
Annuals > 1 > cash Flow > depreciation
546000
Annuals > 1 > cash Flow > change In Working Capital
-616000
Annuals > 1 > cash Flow > cash From Operations
-18858000
Annuals > 1 > cash Flow > capital Expenditures
33000
Annuals > 1 > cash Flow > cash From Investing
-7868000
Annuals > 1 > cash Flow > cash From Financing
25791000
Annuals > 1 > cash Flow > net Change In Cash
-935000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.9117144947565239
Annuals > 1 > ratios > PB
0.0018637878787878788
Annuals > 1 > ratios > ROE
-50.900432900432904
Annuals > 1 > ratios > ROA
-48.35200986943559
Annuals > 1 > ratios > FCF
-18891000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
525000
Annuals > 2 > income Statement > gross Profit
-525000
Annuals > 2 > income Statement > operating Expenses
24932000
Annuals > 2 > income Statement > operating Income
-24932000
Annuals > 2 > income Statement > interest Expense
161000
Annuals > 2 > income Statement > pretax Income
-24669000
Annuals > 2 > income Statement > net Income
-24406000
Annuals > 2 > income Statement > eps
-2.173285841495993
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
11230000
Annuals > 2 > income Statement > income Tax Expense
-263000
Annuals > 2 > income Statement > EBITDA
-24144000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
263000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
4555000
Annuals > 2 > balance Sheet > short Term Investments
34489000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
39436000
Annuals > 2 > balance Sheet > property Plant Equipment
2194000
Annuals > 2 > balance Sheet > total Assets
41661000
Annuals > 2 > balance Sheet > payables
648000
Annuals > 2 > balance Sheet > short Term Debt
314000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
2932000
Annuals > 2 > balance Sheet > equity
38729000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-24669000
Annuals > 2 > cash Flow > depreciation
525000
Annuals > 2 > cash Flow > change In Working Capital
-130000
Annuals > 2 > cash Flow > cash From Operations
-15619000
Annuals > 2 > cash Flow > capital Expenditures
115000
Annuals > 2 > cash Flow > cash From Investing
-34554000
Annuals > 2 > cash Flow > cash From Financing
-4108
Annuals > 2 > cash Flow > net Change In Cash
-50173000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-2.173285841495993
Annuals > 2 > ratios > PB
0.002029745152211521
Annuals > 2 > ratios > ROE
-63.01737715923468
Annuals > 2 > ratios > ROA
-58.58236720193947
Annuals > 2 > ratios > FCF
-15734000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
452909
Annuals > 3 > income Statement > gross Profit
-452909
Annuals > 3 > income Statement > operating Expenses
16892503
Annuals > 3 > income Statement > operating Income
-16892503
Annuals > 3 > income Statement > interest Expense
18709
Annuals > 3 > income Statement > pretax Income
-16527822
Annuals > 3 > income Statement > net Income
-16196413
Annuals > 3 > income Statement > eps
-1.8659840337776434
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
8679824
Annuals > 3 > income Statement > income Tax Expense
-331409
Annuals > 3 > income Statement > EBITDA
-16074915
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
364681
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
54727740
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
55040090
Annuals > 3 > balance Sheet > property Plant Equipment
2604559
Annuals > 3 > balance Sheet > total Assets
57699142
Annuals > 3 > balance Sheet > payables
560000
Annuals > 3 > balance Sheet > short Term Debt
582104
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
3294934
Annuals > 3 > balance Sheet > equity
54404208
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-16527822
Annuals > 3 > cash Flow > depreciation
452909
Annuals > 3 > cash Flow > change In Working Capital
-1144801
Annuals > 3 > cash Flow > cash From Operations
-11845846
Annuals > 3 > cash Flow > capital Expenditures
367890
Annuals > 3 > cash Flow > cash From Investing
-367890
Annuals > 3 > cash Flow > cash From Financing
57606892
Annuals > 3 > cash Flow > net Change In Cash
45393156
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.8659840337776434
Annuals > 3 > ratios > PB
0.001116802729671205
Annuals > 3 > ratios > ROE
-29.77051517779654
Annuals > 3 > ratios > ROA
-28.070457269537908
Annuals > 3 > ratios > FCF
-12213736
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.2252046638551228
Valuation > metrics > PB
0.004791150202057935
Valuation > final Score
70
Valuation > verdict
99.5% Undervalued
Profitability > metrics > ROE
-15.414133867626584
Profitability > metrics > ROA
-14.409981269246645
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.09865181512547967
Risk > metrics > Interest Coverage
-46.283482777577674
Risk > final Score
-125
Risk > verdict
High
Liquidity > metrics > Current Ratio
34.53837719298246
Liquidity > metrics > Quick Ratio
34.53837719298246
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-157
Prev Risks > 1
-102
Prev Risks > 2
-9
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:19:01.905Z
enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease. The company's lead product is the VenoValve, a replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based replacement venous valve system consisting of the enVVe valve, enVVe delivery system, and delivery system accessories. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of enVVeno Medical Corporation
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.